1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The Cognitive & Memory Enhancer Drugs Market is evolving rapidly as demographic trends, advances in pharmaceutical research, and shifting patient needs create new opportunities and challenges for industry stakeholders. Senior decision-makers are navigating a landscape where innovation, regulatory conditions, and supply chain considerations increasingly shape market strategy and clinical development.
Market Snapshot: Cognitive & Memory Enhancer Drugs Market
The cognitive & memory enhancer drugs market grew from USD 6.49 billion in 2024 to USD 7.13 billion in 2025 and is forecast to reach USD 11.26 billion by 2030, representing a robust CAGR of 9.60%. This sustained growth is driven by increasing global demand for therapies addressing cognitive decline, expanded research investment in neurodegenerative diseases, and rising patient and caregiver awareness of cognitive health management.
Scope & Segmentation
- Mechanism of Action: Cholinesterase inhibitors (donepezil, galantamine, rivastigmine), NMDA antagonists, psychostimulants (amphetamines, methylphenidate), racetams (aniracetam, piracetam).
- Dosage Form: Capsules, injectable formulations, oral powders, tablets.
- Applications: Alzheimer’s disease management, attention deficit hyperactivity disorder, general cognitive enhancement, Parkinson’s disease treatment.
- Distribution Channel: Hospital pharmacies, online pharmacies, retail pharmacies.
- End Users: Clinics, hospitals.
- Geographical Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (featuring United Kingdom, Germany, France, Russia, Saudi Arabia, South Africa, and others), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, and more).
- Key Companies Analyzed: Teva Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Novartis AG, Eisai Co., Ltd, AbbVie Inc, Johnson & Johnson, Pfizer Inc, Lundbeck A/S, Biogen Inc, Eli Lilly and Company.
Key Takeaways for Decision-Makers
- Clinical breakthroughs in neurotransmitter modulation and synaptic plasticity research are redefining drug discovery and patient treatment protocols.
- Precision neuropharmacology and AI-powered compound screening are driving targeted therapeutic development, reducing adverse event profiles, and improving patient outcomes.
- The rise of patient-centric care models, including real-time digital monitoring and telehealth, is enhancing engagement, safety, and long-term treatment adherence.
- Strategic alliances between pharma, biotech, and digital health technology providers are strengthening the competitive landscape and supporting data-driven innovation.
- Regional dynamics—such as reimbursement models in the Americas and localized partnerships in Asia-Pacific—necessitate tailored go-to-market and pricing strategies.
- Value-based healthcare trends are prompting a shift toward holistic decision frameworks that include tolerability, delivery convenience, and quality-of-life considerations.
Tariff Impact on Supply Chain & Trade Flows
The targeted United States tariffs introduced in 2025 have reshaped sourcing and manufacturing strategies. Companies are mitigating exposure by exploring domestic production, diversifying supplier bases, and strengthening inventory management. Strategic shifts, including near-shoring and increased reliance on contract manufacturing, emphasize the importance of resilience and adaptability throughout the supply chain.
Methodology & Data Sources
This report combines primary interviews with experts and secondary research from peer-reviewed literature, clinical registries, and corporate disclosures to ensure reliability. Data triangulation, rigorous statistical analysis, and internal peer review protocols were employed to validate insights and present a comprehensive, objective market perspective.
Why This Report Matters
- Delivers actionable intelligence for prioritizing investment, R&D, and partnership opportunities across established and emerging markets.
- Clarifies evolving clinical, regulatory, and supply chain considerations to support strategic planning.
- Supports confident decision-making by offering unbiased, thoroughly vetted findings relevant to executive agendas.
Conclusion
The cognitive & memory enhancer drugs market is defined by scientific progression, evolving patient expectations, and dynamic regulatory conditions. Organizations equipped with strategic segmentation insight and operational agility will be best placed to realize sustainable growth and market leadership.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of digital therapeutics and wearable monitoring to personalize cognitive enhancement regimens
5.2. Expansion of off-label prescription trends among psychiatry practices for memory enhancer polypharmacy protocols
5.3. Surge in investment for biologic and peptide-based nootropics targeting neuroinflammation in Alzheimer’s prevention
5.4. Growth of direct-to-consumer gene-based testing services enabling customized cognitive supplement formulations
5.5. Adoption of microdosed psychedelic compounds in clinical trials to assess long-term memory improvement safety
5.6. Market differentiation through patent filings for slow-release racetam derivatives with improved blood-brain barrier permeability
5.7. Rising consumer demand for plant-derived nootropic blends supported by real-world efficacy data and microbiome research
5.8. Collaborations between pharma companies and AI startups to accelerate discovery of novel synaptic plasticity enhancers
5.2. Expansion of off-label prescription trends among psychiatry practices for memory enhancer polypharmacy protocols
5.3. Surge in investment for biologic and peptide-based nootropics targeting neuroinflammation in Alzheimer’s prevention
5.4. Growth of direct-to-consumer gene-based testing services enabling customized cognitive supplement formulations
5.5. Adoption of microdosed psychedelic compounds in clinical trials to assess long-term memory improvement safety
5.6. Market differentiation through patent filings for slow-release racetam derivatives with improved blood-brain barrier permeability
5.7. Rising consumer demand for plant-derived nootropic blends supported by real-world efficacy data and microbiome research
5.8. Collaborations between pharma companies and AI startups to accelerate discovery of novel synaptic plasticity enhancers
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Cognitive & Memory Enhancer Drugs Market, by Mechanism Of Action
8.1. Introduction
8.2. Cholinesterase Inhibitors
8.2.1. Donepezil
8.2.2. Galantamine
8.2.3. Rivastigmine
8.3. NMDA Antagonists
8.4. Psychostimulants
8.4.1. Amphetamines
8.4.2. Methylphenidate
8.5. Racetams
8.5.1. Aniracetam
8.5.2. Piracetam
8.2. Cholinesterase Inhibitors
8.2.1. Donepezil
8.2.2. Galantamine
8.2.3. Rivastigmine
8.3. NMDA Antagonists
8.4. Psychostimulants
8.4.1. Amphetamines
8.4.2. Methylphenidate
8.5. Racetams
8.5.1. Aniracetam
8.5.2. Piracetam
9. Cognitive & Memory Enhancer Drugs Market, by Dosage Form
9.1. Introduction
9.2. Capsules
9.3. Injectable
9.4. Oral Powder
9.5. Tablets
9.2. Capsules
9.3. Injectable
9.4. Oral Powder
9.5. Tablets
10. Cognitive & Memory Enhancer Drugs Market, by Application
10.1. Introduction
10.2. Alzheimer's Disease
10.3. Attention Deficit Hyperactivity Disorder
10.4. General Cognitive Enhancement
10.5. Parkinson's Disease
10.2. Alzheimer's Disease
10.3. Attention Deficit Hyperactivity Disorder
10.4. General Cognitive Enhancement
10.5. Parkinson's Disease
11. Cognitive & Memory Enhancer Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Cognitive & Memory Enhancer Drugs Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Hospitals
12.2. Clinics
12.3. Hospitals
13. Americas Cognitive & Memory Enhancer Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cognitive & Memory Enhancer Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cognitive & Memory Enhancer Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Limited
16.3.2. Takeda Pharmaceutical Company Limited
16.3.3. Novartis AG
16.3.4. Eisai Co., Ltd
16.3.5. AbbVie Inc
16.3.6. Johnson & Johnson
16.3.7. Pfizer Inc
16.3.8. Lundbeck A/S
16.3.9. Biogen Inc
16.3.10. Eli Lilly and Company
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Limited
16.3.2. Takeda Pharmaceutical Company Limited
16.3.3. Novartis AG
16.3.4. Eisai Co., Ltd
16.3.5. AbbVie Inc
16.3.6. Johnson & Johnson
16.3.7. Pfizer Inc
16.3.8. Lundbeck A/S
16.3.9. Biogen Inc
16.3.10. Eli Lilly and Company
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. COGNITIVE & MEMORY ENHANCER DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COGNITIVE & MEMORY ENHANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. COGNITIVE & MEMORY ENHANCER DRUGS MARKET: RESEARCHAI
FIGURE 26. COGNITIVE & MEMORY ENHANCER DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. COGNITIVE & MEMORY ENHANCER DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. COGNITIVE & MEMORY ENHANCER DRUGS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COGNITIVE & MEMORY ENHANCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. COGNITIVE & MEMORY ENHANCER DRUGS MARKET: RESEARCHAI
FIGURE 26. COGNITIVE & MEMORY ENHANCER DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. COGNITIVE & MEMORY ENHANCER DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. COGNITIVE & MEMORY ENHANCER DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COGNITIVE & MEMORY ENHANCER DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DONEPEZIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DONEPEZIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GALANTAMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GALANTAMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RIVASTIGMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RIVASTIGMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY NMDA ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY NMDA ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY AMPHETAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY METHYLPHENIDATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY METHYLPHENIDATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ANIRACETAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ANIRACETAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PIRACETAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PIRACETAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ORAL POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ORAL POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ATTENTION DEFICIT HYPERACTIVITY DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ATTENTION DEFICIT HYPERACTIVITY DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GENERAL COGNITIVE ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GENERAL COGNITIVE ENHANCEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 110. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 111. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 112. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 113. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 114. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 115. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 116. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 117. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 118. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 119. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 126. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 133. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 134. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 135. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 208. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 209. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 215. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 216. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 217. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 224. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 225. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 231. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 232. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 233. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 256. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 257. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 258. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 259. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 260. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 261. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 262. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 263. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 264. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 265. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 272. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 273. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 279. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 280. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 281. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYC
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DONEPEZIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DONEPEZIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GALANTAMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GALANTAMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RIVASTIGMINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RIVASTIGMINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY NMDA ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY NMDA ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY AMPHETAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY METHYLPHENIDATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY METHYLPHENIDATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ANIRACETAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ANIRACETAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PIRACETAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PIRACETAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ORAL POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ORAL POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ATTENTION DEFICIT HYPERACTIVITY DISORDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ATTENTION DEFICIT HYPERACTIVITY DISORDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GENERAL COGNITIVE ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY GENERAL COGNITIVE ENHANCEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 110. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 111. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 112. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 113. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 114. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 115. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 116. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 117. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 118. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 119. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. CANADA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 126. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 127. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 133. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 134. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 135. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 208. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 209. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 215. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 216. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 217. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. GERMANY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 224. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 225. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 231. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 232. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 233. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. FRANCE COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 256. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 257. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 258. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 259. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 260. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 261. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 262. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 263. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 264. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 265. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. ITALY COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 272. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 273. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY RACETAMS, 2025-2030 (USD MILLION)
TABLE 279. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 280. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 281. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. SPAIN COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYCHOSTIMULANTS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES COGNITIVE & MEMORY ENHANCER DRUGS MARKET SIZE, BY PSYC
Samples
LOADING...
Companies Mentioned
- Teva Pharmaceutical Industries Limited
- Takeda Pharmaceutical Company Limited
- Novartis AG
- Eisai Co., Ltd
- AbbVie Inc
- Johnson & Johnson
- Pfizer Inc
- Lundbeck A/S
- Biogen Inc
- Eli Lilly and Company
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 187 |
| Published | August 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 7.13 Billion |
| Forecasted Market Value ( USD | $ 11.26 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
